PODNL1
gene geneOn this page
Also known as FLJ23447SLRR5B
Summary
PODNL1 (podocan like 1, HGNC:26275) is a protein-coding gene on chromosome 19p13.12, encoding Podocan-like protein 1 (Q6PEZ8).
An extracellular matrix structural constituent. Is active in collagen-containing extracellular matrix.
Source: NCBI Gene 79883 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 130 total
- MANE Select transcript:
NM_001370095
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26275 |
| Approved symbol | PODNL1 |
| Name | podocan like 1 |
| Location | 19p13.12 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ23447, SLRR5B |
| Ensembl gene | ENSG00000132000 |
| Ensembl biotype | protein_coding |
| OMIM | 621043 |
| Entrez | 79883 |
Gene structure
Transcript identifiers
Ensembl transcripts: 17 — 15 protein_coding, 2 protein_coding_CDS_not_defined
ENST00000254320, ENST00000339560, ENST00000538371, ENST00000538517, ENST00000585607, ENST00000586075, ENST00000587288, ENST00000587458, ENST00000587954, ENST00000588317, ENST00000588764, ENST00000588872, ENST00000591353, ENST00000886044, ENST00000886045, ENST00000946318, ENST00000946319
RefSeq mRNA: 5 — MANE Select: NM_001370095
NM_001146254, NM_001146255, NM_001370095, NM_001411137, NM_024825
CCDS: CCDS12300, CCDS54225, CCDS54226, CCDS92538, CCDS92539
Canonical transcript exons
ENST00000588872 — 10 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000685302 | 13933878 | 13933993 |
| ENSE00001385093 | 13935980 | 13936044 |
| ENSE00001385724 | 13934254 | 13934410 |
| ENSE00002770003 | 13931964 | 13932112 |
| ENSE00002839746 | 13932798 | 13933455 |
| ENSE00002900910 | 13931187 | 13931887 |
| ENSE00003461762 | 13936367 | 13936460 |
| ENSE00003486966 | 13937785 | 13938006 |
| ENSE00003583907 | 13935721 | 13935830 |
| ENSE00003816085 | 13938179 | 13938417 |
Expression profiles
Bgee: expression breadth ubiquitous, 132 present calls, max score 85.72.
FANTOM5 (CAGE): breadth broad, TPM avg 2.4287 / max 42.0770, expressed in 888 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 179580 | 1.1186 | 470 |
| 179579 | 0.8107 | 340 |
| 179577 | 0.2517 | 125 |
| 179576 | 0.2476 | 135 |
Top tissues by expression
135 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| tibial nerve | UBERON:0001323 | 85.72 | gold quality |
| right coronary artery | UBERON:0001625 | 84.54 | gold quality |
| apex of heart | UBERON:0002098 | 84.09 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 83.17 | gold quality |
| placenta | UBERON:0001987 | 83.13 | gold quality |
| ascending aorta | UBERON:0001496 | 82.70 | gold quality |
| thoracic aorta | UBERON:0001515 | 82.25 | gold quality |
| left coronary artery | UBERON:0001626 | 81.65 | gold quality |
| sural nerve | UBERON:0015488 | 80.33 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 80.09 | gold quality |
| skin of leg | UBERON:0001511 | 79.99 | gold quality |
| zone of skin | UBERON:0000014 | 79.58 | gold quality |
| skin of abdomen | UBERON:0001416 | 79.27 | gold quality |
| stromal cell of endometrium | CL:0002255 | 78.93 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 78.90 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 78.67 | gold quality |
| vagina | UBERON:0000996 | 78.06 | gold quality |
| popliteal artery | UBERON:0002250 | 77.52 | gold quality |
| tibial artery | UBERON:0007610 | 77.50 | gold quality |
| esophagus mucosa | UBERON:0002469 | 77.07 | gold quality |
| hypothalamus | UBERON:0001898 | 76.44 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 73.39 | gold quality |
| cerebellum | UBERON:0002037 | 73.29 | gold quality |
| cerebellar cortex | UBERON:0002129 | 73.27 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 73.14 | gold quality |
| substantia nigra | UBERON:0002038 | 72.15 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 72.08 | gold quality |
| minor salivary gland | UBERON:0001830 | 71.33 | gold quality |
| endocervix | UBERON:0000458 | 70.57 | gold quality |
| adenohypophysis | UBERON:0002196 | 70.56 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-110499 | no | 8.81 |
| E-ANND-3 | no | 2.39 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
37 targeting PODNL1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4425 | 100.00 | 67.59 | 1049 |
| HSA-MIR-6876-5P | 100.00 | 67.68 | 2126 |
| HSA-MIR-520G-5P | 99.99 | 66.76 | 658 |
| HSA-MIR-1250-3P | 99.96 | 70.04 | 4038 |
| HSA-MIR-6825-5P | 99.96 | 69.81 | 3431 |
| HSA-MIR-4307 | 99.82 | 70.45 | 3374 |
| HSA-MIR-6752-3P | 99.72 | 66.71 | 1587 |
| HSA-MIR-378G | 99.71 | 64.90 | 1106 |
| HSA-MIR-3202 | 99.66 | 67.70 | 2737 |
| HSA-MIR-1252-3P | 99.55 | 67.71 | 2862 |
| HSA-MIR-578 | 99.46 | 68.36 | 1787 |
| HSA-MIR-8077 | 99.17 | 66.67 | 862 |
| HSA-MIR-7160-5P | 99.11 | 67.17 | 2207 |
| HSA-MIR-7151-3P | 99.04 | 69.72 | 2370 |
| HSA-MIR-4451 | 98.82 | 68.17 | 1455 |
| HSA-MIR-5006-5P | 98.79 | 66.92 | 1246 |
| HSA-MIR-6840-3P | 98.68 | 65.95 | 1923 |
| HSA-MIR-5572 | 98.55 | 65.84 | 970 |
| HSA-MIR-7114-3P | 98.42 | 66.53 | 569 |
| HSA-MIR-3187-5P | 98.36 | 65.74 | 1776 |
| HSA-MIR-6773-3P | 98.17 | 65.51 | 1213 |
| HSA-MIR-1285-3P | 97.72 | 67.02 | 1932 |
| HSA-MIR-5189-5P | 97.72 | 66.96 | 1814 |
| HSA-MIR-6812-5P | 97.56 | 65.39 | 1059 |
| HSA-MIR-612 | 97.26 | 65.95 | 1597 |
| HSA-MIR-6860 | 97.21 | 66.31 | 1656 |
| HSA-MIR-4286 | 97.20 | 64.37 | 1587 |
| HSA-MIR-4313 | 97.18 | 63.15 | 420 |
| HSA-MIR-10398-5P | 97.12 | 64.94 | 1051 |
| HSA-MIR-4486 | 96.96 | 60.61 | 931 |
Literature-anchored findings (GeneRIF, showing 1)
- PODNL1 Methylation Serves as a Prognostic Biomarker and Associates with Immune Cell Infiltration and Immune Checkpoint Blockade Response in Lower-Grade Glioma. (PMID:34830454)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Podnl1 | ENSMUSG00000012889 |
| rattus_norvegicus | Podnl1 | ENSRNOG00000006741 |
Paralogs (22): DCN (ENSG00000011465), RTN4R (ENSG00000040608), ASPN (ENSG00000106819), FLRT3 (ENSG00000125848), FLRT1 (ENSG00000126500), LRRC4 (ENSG00000128594), LRRC4B (ENSG00000131409), LRTM1 (ENSG00000144771), LRRC4C (ENSG00000148948), LRRTM1 (ENSG00000162951), LRRC15 (ENSG00000172061), PODN (ENSG00000174348), LRRTM4 (ENSG00000176204), BGN (ENSG00000182492), LRRC19 (ENSG00000184434), FLRT2 (ENSG00000185070), GP1BA (ENSG00000185245), RTN4RL1 (ENSG00000185924), RTN4RL2 (ENSG00000186907), NYX (ENSG00000188937), LRRC66 (ENSG00000188993), LRRTM3 (ENSG00000198739)
Protein
Protein identifiers
Podocan-like protein 1 — Q6PEZ8 (reviewed: Q6PEZ8)
All UniProt accessions (10): A0A2U3TZJ2, B7Z3M0, Q6PEZ8, K7EJ07, K7EMV0, K7EPI2, K7EPR1, K7ER84, K7ERE6, K7ESB1
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Secreted. Extracellular space. Extracellular matrix.
Post-translational modifications. N-glycosylated.
Similarity. Belongs to the small leucine-rich proteoglycan (SLRP) family. SLRP class V subfamily.
Isoforms (4)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q6PEZ8-1 | 1 | yes |
| Q6PEZ8-2 | 2 | |
| Q6PEZ8-3 | 3 | |
| Q6PEZ8-4 | 4 |
RefSeq proteins (5): NP_001139726, NP_001139727, NP_001357024, NP_001398066, NP_079101 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001611 | Leu-rich_rpt | Repeat |
| IPR003591 | Leu-rich_rpt_typical-subtyp | Repeat |
| IPR032675 | LRR_dom_sf | Homologous_superfamily |
| IPR050333 | SLRP | Family |
Pfam: PF13855
UniProt features (28 total): repeat 17, splice variant 3, sequence conflict 3, signal peptide 1, chain 1, domain 1, glycosylation site 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6PEZ8-F1 | 87.24 | 0.82 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (1): 64
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 50 (showing top):
GOMF_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT, NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN, MARSON_BOUND_BY_FOXP3_UNSTIMULATED, chr19p13, GOMF_STRUCTURAL_MOLECULE_ACTIVITY, MIKKELSEN_IPS_LCP_WITH_H3K4ME3, VDR_Q6, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, KRAS.AMP.LUNG_UP.V1_DN, KRAS.300_UP.V1_DN, KRAS.600_UP.V1_DN, GOCC_EXTERNAL_ENCAPSULATING_STRUCTURE, CDC5L_TARGET_GENES, GLI1_TARGET_GENES, ID1_TARGET_GENES
GO Biological Process (0):
GO Molecular Function (2): extracellular matrix structural constituent (GO:0005201), protein binding (GO:0005515)
GO Cellular Component (3): obsolete extracellular space (GO:0005615), extracellular matrix (GO:0031012), extracellular region (GO:0005576)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| structural molecule activity | 1 |
| extracellular matrix | 1 |
| binding | 1 |
| external encapsulating structure | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
658 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| PODNL1 | C19orf67 | A6NJJ6 | 474 |
| PODNL1 | LGALS1 | P09382 | 451 |
| PODNL1 | ADAMTS4 | O75173 | 446 |
| PODNL1 | WRN | Q14191 | 407 |
| PODNL1 | PRKCG | P05129 | 406 |
| PODNL1 | FREM3 | P0C091 | 356 |
| PODNL1 | NYX | Q9GZU5 | 354 |
| PODNL1 | C19orf53 | Q9UNZ5 | 349 |
| PODNL1 | CTHRC1 | Q96CG8 | 328 |
| PODNL1 | RHBG | Q9H310 | 327 |
| PODNL1 | DCAF4L1 | Q3SXM0 | 325 |
| PODNL1 | LRR1 | Q96L50 | 318 |
| PODNL1 | EPYC | Q99645 | 314 |
| PODNL1 | TMED8 | Q6PL24 | 305 |
| PODNL1 | YJU2B | P13994 | 301 |
IntAct
8 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CRP | QSOX1 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNRD2 | CCDC85C | psi-mi:“MI:0914”(association) | 0.530 |
| YWHAQ | PLEKHG3 | psi-mi:“MI:0914”(association) | 0.480 |
| BBS7 | CDK4 | psi-mi:“MI:0914”(association) | 0.350 |
| FTL | psi-mi:“MI:0914”(association) | 0.350 | |
| PCDH20 | CAPN5 | psi-mi:“MI:0914”(association) | 0.350 |
| PYCR3 | ARHGAP32 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (2): PODNL1 (Affinity Capture-MS), PODNL1 (Affinity Capture-MS)
ESM2 similar proteins: A2VDH3, A6H793, B0BNK7, D2HFT7, D4ABX8, E9Q7T7, O75325, P22792, P40197, Q13641, Q149C3, Q1RMS4, Q2EEY0, Q2I0M4, Q3UVD5, Q3UY51, Q4KLL3, Q4R8Y9, Q50LG9, Q5I2M7, Q5I2M8, Q5PQV5, Q5VT99, Q6NUI6, Q6P3Y9, Q6PEZ8, Q6PJG9, Q6UY18, Q6ZSA7, Q7M6Z0, Q7TQ62, Q7Z5L7, Q80WD0, Q80WD1, Q80XU8, Q86UN2, Q86UN3, Q8BHA1, Q8BLY3, Q8K0S5
Diamond homologs: B1H134, B1H234, D3ZTV3, F1NUK7, G5EFX6, G5EG78, O43155, O88280, P19879, P20774, P24014, P58874, P79119, P83286, Q5R6T0, Q5RAC4, Q5RBL2, Q62000, Q6PEZ8, Q6RKD8, Q70AK3, Q810C1, Q8BGT1, Q8BLU0, Q8MJF1, Q96PX8, Q9DE65, Q9NR97, Q9NZU0, Q9NZU1, Q9UBM4, Q9W6H0, O02678, O46378, O46379, O46390, O46403, P21809, P21810, P22792
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
130 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 120 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1079 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:13933452:CTTG:C | acceptor_gain | 1.0000 |
| 19:13933453:TTG:T | acceptor_gain | 1.0000 |
| 19:13933454:TG:T | acceptor_gain | 1.0000 |
| 19:13933456:C:CC | acceptor_gain | 1.0000 |
| 19:13933456:C:CG | acceptor_loss | 1.0000 |
| 19:13933457:T:A | acceptor_loss | 1.0000 |
| 19:13933872:CTGTA:C | donor_loss | 1.0000 |
| 19:13933873:TGTA:T | donor_loss | 1.0000 |
| 19:13933875:TA:T | donor_loss | 1.0000 |
| 19:13933876:A:AC | donor_gain | 1.0000 |
| 19:13933876:A:C | donor_loss | 1.0000 |
| 19:13933877:C:CC | donor_gain | 1.0000 |
| 19:13933989:TTGTT:T | acceptor_gain | 1.0000 |
| 19:13933990:TGTT:T | acceptor_gain | 1.0000 |
| 19:13933991:GTT:G | acceptor_gain | 1.0000 |
| 19:13933992:TT:T | acceptor_gain | 1.0000 |
| 19:13933994:C:CC | acceptor_gain | 1.0000 |
| 19:13933994:C:CG | acceptor_loss | 1.0000 |
| 19:13933995:T:A | acceptor_loss | 1.0000 |
| 19:13934241:A:AC | donor_gain | 1.0000 |
| 19:13934242:C:CC | donor_gain | 1.0000 |
| 19:13936363:TCA:T | donor_loss | 1.0000 |
| 19:13936364:CACCT:C | donor_loss | 1.0000 |
| 19:13936366:C:CT | donor_loss | 1.0000 |
| 19:13937781:CCACC:C | donor_loss | 1.0000 |
| 19:13937782:CACCT:C | donor_loss | 1.0000 |
| 19:13937783:ACCTG:A | donor_loss | 1.0000 |
| 19:13937784:C:CT | donor_loss | 1.0000 |
| 19:13952640:TCA:T | donor_gain | 1.0000 |
| 19:13952640:TCAAG:T | donor_loss | 1.0000 |
AlphaMissense
3645 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000035776 (19:13931315 C>T), RS1000040102 (19:13941248 C>T), RS1000111425 (19:13954049 G>A), RS1000279383 (19:13942143 T>C,G), RS1000880519 (19:13949252 G>A), RS1000983558 (19:13942874 A>G), RS1001041808 (19:13954541 C>G,T), RS1001097555 (19:13949071 T>C,G), RS1001168382 (19:13943594 T>C), RS1001214925 (19:13940356 G>A), RS1001282199 (19:13946749 G>A), RS1001313566 (19:13946933 C>A), RS1001473587 (19:13953469 T>G), RS1001660093 (19:13953913 G>A), RS1001839602 (19:13953255 C>G,T)
Disease associations
OMIM: gene MIM:621043 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
20 total (human), top 20 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Particulate Matter | decreases expression, increases abundance | 2 |
| propionaldehyde | increases expression | 1 |
| deoxynivalenol | decreases expression | 1 |
| ethyl-p-hydroxybenzoate | decreases expression | 1 |
| sodium arsenite | increases expression | 1 |
| nutlin 3 | affects cotreatment, increases expression | 1 |
| licochalcone B | increases expression | 1 |
| Dasatinib | increases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Air Pollutants | increases abundance, decreases expression | 1 |
| Atrazine | increases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Camptothecin | increases expression | 1 |
| Dactinomycin | affects cotreatment, increases expression | 1 |
| Estradiol | affects cotreatment, increases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Okadaic Acid | decreases expression | 1 |
| Lactic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.